Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial

Kristy Coleman, Elizabeth Finger, Adam L. Boxer et al.|The Lancet Neurology|2025

Cited by 17